Prediction and Prevention of Preeclampsia
The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring C-reactive protein levels in a biological sample of a pregnant woman. The disclosure further encompasses methods of reducing risk of preeclampsia through administration of a pharmaceutical formulation of relaxin to a pregnant woman.
STEWART DENNIS R [US]; CONRAD KIRK P [US]; JEYABALAN ARUNDHATHI [US]
Type of Offer:
« More Pharmaceutical Patents« More Diagnostic Patents